Pages that link to "Q6822173"
Jump to navigation
Jump to search
The following pages link to mesulergine (Q6822173):
Displayed 21 items.
- HEK293 (Q489618) (← links)
- 5-hydroxytryptamine receptor 2A (Q1949517) (← links)
- 5-hydroxytryptamine receptor 2B (Q4639596) (← links)
- 5-hydroxytryptamine receptor 2C (Q21108118) (← links)
- 5-hydroxytryptamine receptor 7 (Q21109355) (← links)
- 5-hydroxytryptamine receptor 6 (Q21109363) (← links)
- 5-hydroxytryptamine (serotonin) receptor 7 (Q21497939) (← links)
- Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties (Q24338659) (← links)
- Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors (Q34251036) (← links)
- Antihypertensive effects of mesulergine: further evidence for a peripheral site of action of dopamine agonists (Q41338988) (← links)
- Mechanism of action and tolerance of mesulergine (Q42250459) (← links)
- Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats. (Q42770157) (← links)
- Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol, and mesulergine (Q45068585) (← links)
- Mesulergine, a new dopamine agonist: effects on anterior pituitary function and kinetics (Q48608433) (← links)
- Influence of serotonergic 5-HT2C receptor antagonist mesulergine in the reversal of memory deficits induced by mCPP. (Q50968752) (← links)
- Parkinson's disease: a comparison of mesulergine and bromocriptine. (Q52082334) (← links)
- Mesulergine (CU 32-085) in the treatment of Parkinson's disease (Q69508857) (← links)
- Placebo-controlled study of mesulergine in Parkinson's disease (Q69882168) (← links)
- Dopaminergic properties of mesulergine (CU 32-085) and its metabolites (Q70756896) (← links)
- Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism (Q93649527) (← links)
- Wikidata:Database reports/Constraint violations/P2275 (← links | edit)